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Sirtuin 2 is a nicotinamide-adenine-dinucleotide-
dependent deacetylase that regulates cell processes
such as carcinogenesis, cell cycle, DNAdamage, and
infection. Subcellular localization of SIRT2 is crucial
for its function but is poorly understood. Infection
with the bacterial pathogen Listeria monocytogenes,
which relocalizes SIRT2 from the cytoplasm to the
chromatin, provides an ideal stimulus for the molec-
ular study of this process. In this report, we provide a
map of SIRT2 post-translational modification sites
and focus on serine 25 phosphorylation. We show
that infection specifically induces dephosphorylation
of S25, an event essential for SIRT2 chromatin asso-
ciation. Furthermore, we identify a nuclear complex
formed by the phosphatases PPM1A and PPM1B,
with SIRT2 essential for controlling H3K18 deacetyla-
tion and SIRT2-mediated gene repression during
infection and necessary for a productive Listeria
infection. This study reveals a molecular mechanism
regulating SIRT2 function and localization, paving
the way for understanding other SIRT2-regulated
cellular processes.INTRODUCTION
Originally identified in yeast as regulators of anti-aging
genes, sirtuins form a family of highly conserved nicotinamide-
adenine-dinucleotide (NAD)-dependent deacetylases. Seven
mammalian sirtuins have been identified, and although
they share a common catalytic domain, they are differentially
localized in the cell. SIRT1—the closest homolog to yeast
sirtuins—along with SIRT6 and SIRT7, is a nuclear protein, while
SIRT3, SIRT4, and SIRT5 are exclusively found in mitochondria
(Michan and Sinclair, 2007). SIRT2 was first shown to colocalize
with microtubules in the cytoplasm but was also found in the
nucleus under certain situations (North et al., 2003). The proper1124 Cell Reports 23, 1124–1137, April 24, 2018 ª 2018 The Authors
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and Sinclair, 2007).
The function of SIRT2 has mainly been characterized in the
cytoplasm, where it regulates microtubule dynamics, nuclear
factor kB (NF-kB) signaling, and adipocyte differentiation by
deacetylating, respectively, alpha-tubulin, p65, and the transcrip-
tion factor FOXO1 (Gomes et al., 2015). Importantly, SIRT2 regu-
lates cytoplasmic metabolism by sensing NAD levels and target-
ing proteins involved in metabolic homeostasis, such as aldolase
and phosphoglycerate kinase (Cha et al., 2017; Gomes et al.,
2015). Besides cytoplasmic substrates, SIRT2 has also been
shown to target nuclear proteins, such as p53, the histone acetyl-
transferase p300, and various histones (Eskandarian et al., 2013;
de Oliveira et al., 2012). SIRT2 has also been reported to be nu-
clear during mitosis, where it deacetylates histone H4 at lysine
16 to modulate chromatin condensation during the G2/M transi-
tion of the cell cycle while constitutively shuttling in and out of the
nucleus in interphase cells (Inoue et al., 2007; North and Verdin,
2007a; Vaquero et al., 2006). However, the molecular features
that dictate the substrate specificity of SIRT2 and its cellular
localization remain completely unknown.
Entrance into the nucleus occurs through the nuclear pore
complex (NPC), a macromolecular channel that limits free diffu-
sion of proteins larger than approximately 40 kDa. Classically,
larger proteins require binding to importin receptors that recog-
nize primary amino acid sequences, called nuclear localization
sequences (NLSs). The molecular mass of SIRT2, 43 kDa, which
is close to the limit of size exclusion from the NPC, raises the
question of whether SIRT2 is actively imported or diffuses freely
into the nucleus. Sequence analysis has not revealed a canonical
NLS motif for SIRT2, suggesting that nuclear import is not regu-
lated (North and Verdin, 2007a). Nuclear localization can also be
controlled by regulation of nuclear export, which is mediated by
nuclear exporters such as the Chromosome region maintenance
1 (CRM1). SIRT2 has a nuclear export sequence (NES)
and rapidly accumulates in the nucleus after treatment with
Leptomycin B, a chemical inhibitor of the CRM1-dependent
export (North and Verdin, 2007a), indicating that SIRT2 is actively
exported from the nucleus. Removal of the NES from SIRT2 has
a much greater effect on nuclear localization as compared to the
addition of an NLS motif (Rothgiesser et al., 2010). NLS- and.
creativecommons.org/licenses/by-nc-nd/4.0/).
NES-dependent transport can be regulated by mechanisms
such as post-translational modifications (PTMs) of the cargo,
including phosphorylation, methylation, and ubiquitination, but
no such process has been described for SIRT2 (Martin et al.,
2007; Terry et al., 2007; Xu and Massague´, 2004). Additionally,
the lack of known stimuli inducing nuclear localization of SIRT2
has made the study of such a process difficult.
One recently identified stimulus, which led to the relocalization
of SIRT2 to the nucleus, is infection with Listeria monocytogenes
(Eskandarian et al., 2013). This bacterium is the causative agent
of the disease listeriosis, which starts by the ingestion of
contaminated food and is a problem mainly for immuno-
compromized patients and pregnant women. At the cellular
level, L. monocytogenes is well adapted to exploit host cells
for its benefit through very sophisticated mimicry and interac-
tions with host proteins (Cossart, 2011). Our previous studies
have shown that infection hijacks SIRT2, relocalizes it to the nu-
cleus where SIRT2 associates to chromatin, and targets histone
H3 for deacetylation on lysine 18 at the transcription start site of
genes repressed during infection (Eskandarian et al., 2013; Fig-
ure 1A). Therefore, infection provides an optimal model to study
the molecular mechanism of nuclear accumulation of SIRT2.
Previous reports have described phosphorylations of SIRT2,
but these modifications did not alter its cellular localization
(Nahhas et al., 2007; North and Verdin, 2007b). Therefore, we
hypothesized that a yet-unidentified PTM of SIRT2 could be
the molecular feature regulating nuclear localization. To
address this point, we carried out a systematic identification
of SIRT2 PTMs by mass spectrometry (MS), and we reveal
Serine 25 phosphorylation as a critical modification site. The
phosphorylation state of this residue determines SIRT2 chro-
matin association during L. monocytogenes infection. We iden-
tified the molecular complex assembled during infection, which
dephosphorylates SIRT2-S25; it is composed of the phospha-
tases PPM1A and PPM1B. We further show that serine 25
dephosphorylation, and the activity of the underlying machinery
is necessary for H3K18 deacetylation and transcriptional regu-
lation during infection and essential for L. monocytogenes
infection efficiency.
RESULTS
Amino Acids 1–37 Are Important for Chromatin
Association of SIRT2 upon Infection
L. monocytogenes induces a relocalization of SIRT2 from the
cytoplasm to chromatin, revealing a new role for SIRT2 in chro-
matin association and transcriptional regulation (Eskandarian
et al., 2013; Figure 1A). SIRT2 is expressed as two major vari-
ants: the full-length protein, isoform 1 (398 amino acids [aa]),
and a shorter splice variant, isoform 2 (352 aa), which lacks the
first 37 aa (Figure 1B). To determine which isoform was being
relocalized during infection, isoforms 1 and 2 were expressed
separately as tagged proteins, and cellular localization was
determined by immunoblotting cell fractionations of infected
and control cells (Figures 1B and S1). While isoform 1 is present
in the chromatin fraction in very small amounts in uninfected cells
(less than 2%), 11% of the protein becomes relocalized to this
fraction upon infection. In contrast, isoform 2 does not translo-cate to chromatin and is present at less than 2% in this fraction
upon infection. Therefore, only isoform 1 associates with chro-
matin in infected cells, suggesting that a molecular feature
contributing to nuclear localization is present in the first 37 aa
and is absent from isoform 2.
We hypothesized that SIRT2 is post-translationally modified
upon infection and used MS to identify such features. We immu-
noprecipitated SIRT2 (isoform 1) from cells that had been
infected and fractionated, then we performed MS using higher
energy collisional dissociation (HCD) fragmentation (Figure 1C).
This analysis identified the 2 residues previously described as
being modified, S368 and S372, but also several other modifica-
tions which had not been reported, including 12 serine and 2
threonine phosphorylation sites, 3 ubiquitinylation sites, and 6
acetylation sites. Of note, several of the phosphorylation sites
were found on neighboring residues that are present on the
same tryptic peptide. The low localization probability for these
sites indicates that the exact location of the modified residue
cannot be determined by HCD fragmentation of the peptide,
leaving the possibility that only one of the neighboring residues
is primarily modified (Figure 1C).
Interestingly for this study, a cluster of serine residues near the
N terminus of SIRT2, present only in isoform 1, was detected as
being phosphorylated in the cytoplasmic fraction but never in the
chromatin fraction. Indeed, the presence of phosphopeptides,
as depicted with a plus symbol in Figure 1C, was detected in
the cytosol of infected cells, but only unmodified peptides, noted
with aminus symbol in Figure 1C, were detected in the chromatin
fraction. These results suggest that when SIRT2 isoform 1 is
associated with chromatin upon infection, it is dephosphorylated
on these residues.
SIRT2 Is Dephosphorylated on S25 upon Infection
Upon trypsin digestion, S23, -25, and -27 are present on the
same peptide, and HCD fragmentation of this peptide
cannot sort out which serine residue is phosphorylated. To
determine which of these serine residues were modified,
immunoprecipitated SIRT2 from whole-cell extracts was used
for MS analysis using electron-transfer dissociation (ETD) as an
alternative fragmentation method (Chi et al., 2007). Figure 2A
shows a representative ETD spectrum of the tryptic SIRT2 phos-
pho-peptide H2N-17VQEAQDSDSDSEGGAAGGEADMDFLR42-
COOH, clearly identifying S25 (indicated as an S below an
asterisk) as the residuemodified.Quantificationof this phosphor-
ylated peptide relative to the native peptide revealed that 45%of
the detected SIRT2 peptide is phosphorylated at serine 25 in
resting cells (Figure 2B). We further compared the phosphoryla-
tion levels between infected and uninfected cells and reveal a
striking decrease in phosphorylated S25 but not phosphorylated
S368 (Figure 2C). Therefore, we conclude that infection leads
to a significant decrease in SIRT2 phosphorylation, specifically
at S25.
S25 Dephosphorylation Is Necessary for Chromatin
Association and H3K18 Deacetylation
In order to investigate the role of SIRT2 dephosphorylation in
subcellular relocalization, we constructed a phospho-mimetic
mutant of S25 (S25E), in which we also mutated adjacent S23Cell Reports 23, 1124–1137, April 24, 2018 1125
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Figure 1. SIRT2 Is Post-translationally Modified, and Chromatin Association Requires Amino Acids 1–37
(A) Schematic representation of the effect of L. monocytogenes on the subcellular localization of SIRT2. SIRT2 is mainly localized in the cytoplasm in uninfected
conditions and translocates to the nucleus, where it associates with chromatin to cause H3K18 deacetylation at the transcriptional start site (TSS) of genes
repressed during infection.
(B) Schematic representation of SIRT2 isoform 1 and isoform 2 and the identified serine 25 phosphorylation site. Isoform 1 is the full protein (389 aa), while isoform
2 lacks 37 aa from the N terminus. Histograms represent the mean SIRT2 levels in fractionated cells, immunoblotted and quantified in each fraction normalized to
total SIRT2. Error bars represent SEM of at least 3 independent experiments. *p < 0.05, as measured with Student’s t test. Both isoforms are present in the
cytoplasm, but only isoform 1 associates to chromatin during infection.
(C) Flow diagram of themass spectrometry experiment and a table listing SIRT2modification sites identified in different subcellular fractions. Columns from left to
right indicate the position of the modified serine (S), threonine (T), or lysine (K) residue in the SIRT2 protein sequence, the localization probability as a measure of
the mapping precision of the identified modification, and an indication of whether the modification was detected (+) or not detected () in each of the subcellular
fractions.and S27 to glutamic acid in addition to serine 25 in order to
minimize the compensatory effects of these residues. We also
created a dephospho-mimetic mutant by changing the serine
to a charged amino acid, alanine (S25A). Additionally, we gener-
ated a phospho-mimeticmutant of S368 (S368E) to use as a con-
trol in our assay. By fluorescence microscopy, we evaluated the
cellular localization of these constructs with and without infec-
tion (Figure 3A). We observed that the S25E and S25A mutants1126 Cell Reports 23, 1124–1137, April 24, 2018were localized in the cytoplasm of uninfected cells as well as
the wild-type (WT) SIRT2 and the S368E mutant. Upon infection,
all the constructs could be detected in the nucleus, indicating
that neither S25E nor S25A, nor S368E mutants are impaired in
nuclear relocalization upon infection. Subcellular localization
was then evaluated by cell fractionation, which separates the
soluble nuclear fraction from the insoluble chromatin fraction,
followed by western blotting (Figures 3B and S2). WT SIRT2
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Figure 2. Serine 25 Is Dephosphorylated upon Listeria Infection
(A) Flow diagram of the mass spectrometry experiment and annotated ETD fragmentation spectrum of the identified tryptic SIRT2 peptide carrying the modified
serine residue at position 25. The sequence of the peptide is shown above the spectrum, andmatching c- and z-fragment ion series are indicated, clearly pointing
toward S25 as the modified residue (highlighted by asterisk).
(B) Phosphorylation levels of the indicated peptide were calculated as theMS1 intensity of detection of phosphorylated peptide over that of both themodified and
non-modified peptides. Error bars represent SEM of 3 technical replicates of at least 3 independent experiments.
(C) Intensity of detection of the peptide containing phosphorylated S25, phosphorylated S368, and the corresponding unmodified peptides as determined by
ETD fragmentation. Error bars show SEM of 3 technical replicates of a representative experiment (nR 3). **p < 0.01; ns, pR 0.05, as measured with Student’s
t test.and the S368E mutant strongly relocalize to the chromatin
fraction upon infection. Strikingly the S25A mutant was also
detected in the chromatin fraction upon infection, while a S25E
mutant was not. Together, these data indicate that a mutant
of SIRT2 that is locked in a pseudo-unphosphorylated state
at S25 is able to associate to chromatin upon infection
with L. monocytogenes, whereas a mutant locked in a pseudo-
phosphorylated state is impaired.
SIRT2 activity is required for inducing H3K18 deacetylation
and necessary for a productive L. monocytogenes infection
(Eskandarian et al., 2013). In order to study the role of SIRT2-
S25E in a background lacking endogenous SIRT2, we needed
a cell line depleted of endogenous SIRT2 in which we could ex-
press SIRT2-S25E. To achieve this goal, we first generatedSIRT2/ and WT mouse embryonic fibroblasts (MEFs) and
immortalized them by transformation with the simian virus 40
(SV40) large T antigen. These cell lines were assayed for their
phenotype upon infection by quantifying the number of intracel-
lular GFP bacteria per cell by fluorescence-activated cell sort-
ing (FACS) analysis at 5 hr and 24 hr post-infection (Figure 3C).
We observed that there was no significant difference between
the levels of intracellular bacteria in WT and SIRT2/ MEFs
at 5 hr post-infection, suggesting no defect in invasion. How-
ever, at 24 hr post-infection, SIRT2 knockout MEFs showed
40% less intracellular bacteria compared to WT MEFs. These
results are in agreement with our previous findings in infected
epithelial cells inhibited for SIRT2 activity and our in vivo find-
ings using SIRT2 knockout (KO) mice (Eskandarian et al.,Cell Reports 23, 1124–1137, April 24, 2018 1127
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Figure 3. Serine25 Dephosphorylation Is Important for SIRT2 Relocalization and Activity at Chromatin
(A) Images of HeLa cells transfected with GFP fused to WT-SIRT2, SIRT2-S25E, SIRT2-S25A, SIRT2-S368E, and isoform 2, under uninfected (-) and infected (+)
conditions. Scale bars, 10 mm.
(B) Cell fractionations of indicated SIRT2 mutants under uninfected () and infected (+) conditions. Representative image of nR 3.
(C) WT MEFs or Sirt2/ MEFs were infected with L. monocytogenes expressing GFP for the indicated times. Intracellular bacteria were detected by FACS
analysis, and the geometric mean (mean fluorescence of intensity; MFI) of 10,000 cells was calculated. Results are normalized to uninfected cells and averaged
over at least 3 independent experiments.
(D) Sirt2/ MEFs were transfected with the indicated SIRT2 constructs, uninfected (dark gray), or infected (light gray) with L. monocytogenes for 5 hr. H3K18
acetylation levels were determined by immunoblotting and normalized to the total a-tubulin level.
Error bars represent SEM of at least 3 independent experiments. Statistical significance was calculated using a Student’s t test. **p < 0.01.2013). In order to assess the role of SIRT2 phosphorylation on
H3K18 deacetylation during infection, we transfected SIRT2/
MEFs with isoform 2, WT isoform 1, the S25E mutant, or an
empty overexpression vector and quantified the H3K18Ac
levels (Figures 3D and S3). We observed that, in cells comple-
mented with WT isoform 1, H3K18Ac levels were lower after
infection, indicating that this construct is able to induce
H3K18 deacetylation in vivo. The small level of deacetylation
observed reflects the low transfection efficiency in MEF
cells (40%–50%). However, no decrease was observed with
SIRT2-S25E or isoform 2, or by overexpression of EGFP tag
alone. These results show that both the S25E mutant and iso-
form 2, which do not associate with chromatin, are impaired in
H3K18 deacetylation during infection.1128 Cell Reports 23, 1124–1137, April 24, 2018SIRT2 Interacts with PPM1A and PPM1B Phosphatases
upon Infection
Phosphatases targeting SIRT2 have not been identified. In
order to find the molecular players involved in SIRT2 dephos-
phorylation during infection, we immunoprecipitated SIRT2
and performed MS analysis on all proteins recovered. Our pre-
liminary analysis suggested that SIRT2 interacts with PP2C
phosphatases PPM1A and PPM1B (data not shown). To
confirm the interaction of SIRT2 with these phosphatases,
we performed co-immunoprecipitations from whole-cell ly-
sates of cells overexpressing both SIRT2-GFP and PPM1A-
FLAG. By immunoprecipitating SIRT2-GFP, PPM1A-FLAG
was recovered, supporting the finding that the two proteins
interact (Figure 4A). Interestingly, under these conditions,
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Figure 4. SIRT2 Interacts with Protein Phosphatases 1A and 1B upon Infection
(A and B) Shown here: (A) SIRT2-GFP and (B) PPM1A-FLAG immunoprecipitations under uninfected () and infected (+) conditions. Constructs are listed at the
top, and antibodies are indicated next to the corresponding immunoblots. Images are representative of 3 experiments.
(C) Cells were treated with sanguinarine chloride for 24 hr. SIRT2 was immunoprecipitated and analyzed by mass spectrometry using ETD fragmentation.
Phosphorylation levels of the indicated residue were calculated as the intensity of detection of phosphorylated peptide over that of both the modified and
non-modified peptides.
Error bars represent SEM of 3 technical replicates of at least 3 independent experiments. Statistical significance was calculated using Student’s t test. **p < 0.01;
ns, pR 0.05.PPM1A is recovered mainly upon infection, suggesting that
L. monocytogenes might enhance the interaction of PPM1A
with SIRT2. We further performed co-immunoprecipitations
to determine whether we could recover endogenous proteins
(Figures 4B and S4). Upon overexpressing PPM1A-FLAG,
both endogenous SIRT2 and PPM1B were recovered, and,
upon overexpressing of a catalytically inactive PPM1B mutant
(PPM1B-R179G-FLAG), a catalytically inactive PPM1B mutant
was used to capture transient interactions (Chen et al., 2015;
Kusuda et al., 1998), endogenous PPM1A was recovered.
We used another protein, Drp1-FLAG, as a negative control
in our immunoprecipitations and showed that, besides a slight
interaction with PPM1B, no other proteins are recovered.Altogether, these results strongly support that PPM1A and
PPM1B form a complex with SIRT2.
To determine the role of PPM1A and PPM1B in dephosphory-
lation of SIRT2, we treated cells with sanguinarine chloride, a
pharmacological inhibitor of the PP2C phosphatase family
(Aburai et al., 2010; Schaaf et al., 2017) and analyzed the levels
of S25 and S368 phosphorylation by MS. By measuring the MS
intensities of the phospho-peptides and normalizing to the total
peptide intensity, we observed that the basal level of S25 phos-
phorylation increased significantly after sanguinarine treatment,
whereas no significant change is observed for S368 (Figure 4C).
These results indicated that the activity of PPM1A and PPM1B
plays a role in the phosphorylation status of SIRT2 at S25.Cell Reports 23, 1124–1137, April 24, 2018 1129
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Figure 5. Protein Phosphatases 1A and 1B Relocalize to Chromatin upon Infection
(A) Immunofluorescence of endogenous PPM1B and PPM1A under uninfected () and 5-hr-infected (+) conditions. Scale bars, 10 mm.
(B) Live-cell imaging of HeLa cells showing SIRT2 (green) and PPM1B (red). Still images were acquired every 2 min after 1 hr of infection. Merged and single
channels show the dynamics of SIRT2 and PPM1B subcellular localization during infection. Scale bars, 10 mm.
(C) Immunoblot of cell fractionation under uninfected () and 5-hr-infected (+) conditions. PPM1B-FLAG and endogenous PPM1A were revealed with antibodies
against FLAG and PPM1A, respectively. Tubulin, CRM1, and histone H3 were used to control fraction purity. Image is representative of at least 3 experiments.As SIRT2 relocalizes to the nucleus upon infection, we studied
the cellular location of endogenous PPM1A and PPM1B (Fig-
ure 5A). Although PPM1A is detected both in the cytoplasm
and the nucleus of uninfected cells, PPM1B is mainly detected
in the cytoplasm. Upon infection, PPM1A staining does not
significantly change. In contrast, PPM1B staining clearly be-
comes nuclear, suggesting that infection induces the relocaliza-
tion of PPM1B protein to the nucleus (Figure 5A). We further1130 Cell Reports 23, 1124–1137, April 24, 2018focused on PPM1B for the study of the dynamics of relocaliza-
tion upon infection. Live-cell imaging experiments were con-
ducted in cells overexpressing WT SIRT2 and PPM1B before
and after infection with L. monocytogenes. In uninfected cells,
both SIRT2 and PPM1B remained localized in the cytoplasm of
transfected cells (Figure S5). In infected cells, PPM1B and
SIRT2 localized exclusively in the cytoplasm until 70 min post-
infection (Figure 5B). Then, relocalization of both PPM1B and
SIRT2 occurred. By 82 min post-infection, all four imaged cells
showed relocalization of both PPM1B and SIRT2 to the nucleus.
This relocalization occurred in synchrony for PPM1B and SIRT2.
The subcellular localization of the phosphatases was further
characterized by fractionation of cells overexpressing WT
PPM1B uninfected or infected with L. monocytogenes (Fig-
ure 5C). While both endogenous PPM1A and overexpressed
PPM1B were absent from the chromatin fraction in uninfected
cells, a strong band corresponding to these proteins was de-
tected in this fraction in infected cells, indicating that, as for
SIRT2, Listeria infection induces the relocalization of PPM1A
and PPM1B to chromatin.
PPM1A and PPM1B Are Necessary for SIRT2
Dephosphorylation and Chromatin Association during
Infection
We studied the role of PPM1A and PPM1B on SIRT2
phosphorylation during infection by blocking the activity of
these phosphatases with sanguinarine and evaluating the
levels of phosphorylated S25 and S368 by MS (Figure 6A).
While infection decreased S25 phosphorylation levels
from 25% to less than 5% in untreated cells, in cells treated
with sanguinarine, infection only decreased phosphorylation
levels from 40% to 30%, indicating that PPM1A and PPM1B
inhibition blocked S25 dephosphorylation. This effect is
specific to S25, as neither sanguinarine nor infection modified
the levels of S368 phosphorylation.
Since serine 25 dephosphorylation is necessary for chromatin
association, we studied the role of PPM1A and PPM1B in SIRT2
translocation to chromatin during infection. By fluorescence
microscopy, SIRT2-GFP was monitored upon infection in the
presence of sanguinarine (Figure 6B). Both in untreated and in
sanguinarine-treated cells, we could observe that SIRT2 was
localized in the cytoplasm in uninfected cells and relocalized to
the nucleus upon infection to the same extent in both conditions.
Cell fractionation was performed to measure the level of chro-
matin association of SIRT2 upon sanguinarine treatment (Fig-
ure 6C). Immunoblot analysis of the cellular fractions showed
that sanguinarine treatment impairs chromatin association
during infection, as compared to untreated cells. Therefore,
blocking PPM1A and PPM1B activity with sanguinarine affected
chromatin association but not translocation to the nucleus.
These results are in agreement with our data showing that a
phospho-mimetic S25E SIRT2 mutant is similarly impaired in
translocation to chromatin.
PPM1B and PPM1A Are Necessary for SIRT2 Function
during Infection
We next assessed the impact of PPM1A and PPM1B on SIRT2
function during infection. PPM1A and PPM1B were depleted
by small interfering RNA (siRNA) treatment, or their activity
was blocked with sanguinarine, and we evaluated the effect on
infection-induced H3K18 deacetylation. In control siRNA, we
observed a significant decrease in the levels of H3K18Ac upon
infection, which did not occur in PPM1A and PPM1B siRNA-
treated cells (Figure 7A). However, treating cells with siRNA
against an unrelated phosphatase (PP1) had no effect on
H3K18 deacetylation. In agreement with these results, cellstreated with sanguinarine are also blocked in H3K18 deacetyla-
tion (Figure 7A).
The impact of PPM1A and PPM1B on Listeria infection was
measured by quantifying bacterial levels upon siRNA or sangui-
narine treatment. Cells were assayed 24 hr post-infection for the
levels of a listerial housekeeping protein, EF-Tu, used as a
readout of infection. Knocking down PPM1A or PPM1B with
siRNA reduced intracellular Listeria levels by 40%, compared
to control cells (Figure 7B), i.e., to the same extent as in knockout
MEFs in Figure 4A. In agreement with these results, blocking
PPM1A and PPM1B activities by sanguinarine treatment caused
a similar reduction in Listeria levels.
Our previous studies by chromatin immunoprecipitation
revealed that SIRT2 associated with the transcriptional start
site of genes repressed during infection and that SIRT2 activity
was necessary for gene repression upon infection (Eskandarian
et al., 2013). To evaluate whether phosphorylation of S25 is
necessary for transcriptional regulation by SIRT2, we character-
ized the role of PPM1A and PPM1B in this process after RNAi
knockdown (Figure 7C). qPCR was used to evaluate the expres-
sion levels of genes previously shown to be regulated in a SIRT2-
dependent manner. We compared PPM1B siRNA-treated cells
to control cells upon infection. As we previously reported, we
observed, in control cells, a significant expression level decrease
for genes repressed during infection in a SIRT2-dependent
manner (MYLIP, EHHADH, and ERCC5) and an increase for
genes activated independently of SIRT2 (EMP1, TIPARP, and
SDC4). Upon inactivation of PPM1B by siRNA knockdown,
infection-induced repression was completely blocked. In
contrast, infection-induced activation was not affected by siRNA
treatment. Therefore, these results show that blocking PPM1B
has a specific effect on genes repressed in a SIRT2-dependent
manner.
DISCUSSION
In this study, we have performed a comprehensive analysis of
SIRT2 PTMs and focused on serine 25 phosphorylation, which
is located in the N-terminal part of SIRT2. Most notably, we
revealed that dephosphorylation of S25 is necessary for
SIRT2 chromatin association upon infection with the bacterium
L. monocytogenes. We further identify two phosphatases,
PPM1A and PPM1B, which dephosphorylate S25, form a com-
plex with SIRT2 upon infection, and relocalize to the chromatin
fraction simultaneously with SIRT2. Indeed, knocking out or in-
activating the phosphatases phenocopies a SIRT2 knockout
with regard to its effect on histone modifications, transcriptional
regulation, and infection efficiency. S25 dephosphorylation is,
therefore, essential for SIRT2 activity at the chromatin fraction
during infection with L. monocytogenes.
Before our study, only two SIRT2 PTMs had been examined,
S368 and S372 phosphorylation, and a few others had been
identified by high-throughput phosphoproteomic screens (Flick
and L€uscher, 2012; Hornbeck et al., 2015). S368, which is phos-
phorylated by the Cdk1 kinase, was shown to play a role in
SIRT2-mediated mitotic delay, while no role has been identified
for S372 phosphorylation (Nahhas et al., 2007; North and Verdin,
2007b). We had previously revealed new properties for SIRT2 inCell Reports 23, 1124–1137, April 24, 2018 1131
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Figure 6. The Activity of PPM1A and PPM1B Is Necessary for SIRT2 Dephosphorylation and Chromatin Association
(A) SIRT2 was immunoprecipitated upon sanguinarine treatment from uninfected () or 5-hr-infected (+) cells and analyzed by mass spectrometry using ETD
fragmentation. Phosphorylation levels of the indicated residue were calculated as the intensity of detection of phosphorylated peptide over that of both the
modified and non-modified peptides.
(B) SIRT2-GFP images under uninfected () and 5-hr-infected (+). Scale bars, 10 mm. Experiments are representative of nR 3.
(C) Immunoblot of cell fractionation under uninfected () and 5-hr-infected (+) conditions. Tubulin, CRM1, and histone H3 were used to control fraction purity.
Error bars represent SEM of at least 3 independent replicates. *p < 0.05, as measured with a Welch two-sample t test.chromatin association, H3K18 deacetylation, and transcriptional
regulation. We now show that S25 is the crucial residue that
needs to be dephosphorylated to allow such SIRT2 activity
and dictates SIRT2 subcellular localization.
In the literature, SIRT2 has been mainly characterized as a
cytoplasmic deacetylase (North et al., 2003). Nuclear localization1132 Cell Reports 23, 1124–1137, April 24, 2018of SIRT2 has been observed in a very small percentage of resting
cells and shown to accumulate in the nucleus upon Leptomycin
B treatment (North and Verdin, 2007a). In fact, SIRT2 was shown
to shuttle in and out of the nucleus in resting cells and be actively
exported by Crm1-dependent nuclear export signal located in
the N terminus between residues 41 and 51. We have previously
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Figure 7. PPM1A and PPM1B Are Necessary for SIRT2 Function
(A) Immunoblots of cells transfected with the indicated siRNAs or preteated with sanguinarine chloride, uninfected () or 5-hr-infected (+).
(B) Bacterial levels as measured by immunoblotting against the Listerial protein EF-Tu in cells transfected with siRNA or treated with sanguinarine chloride. Cells
were infected with L. monocytogenes EGD-e PrfA* for 24 hr. Quantifications of immunoblots are normalized to a-tubulin and to the control sample.
(C) Relative mRNA expression as detected by qPCR normalized to uninfected samples and to GAPDH. Infection-dependent repressed genes are highlighted in
red, while infection-activated genes are highlighted in blue.
*p < 0.05; ***p < 0.001, as measured with Student’s t test on the DCT values. Error bars represent SEM of at least 3 independent experiments.shown that nuclear accumulation of SIRT2 with Leptomycin B
does not lead to H3K18 deacetylation, suggesting that an addi-
tional signal is required for chromatin association (Eskandarian
et al., 2013). The mechanism for nuclear accumulation, which
is a prerequisite for chromatin association but is independent,
is unknown but could involve one of the modifications that we
identified by MS. It is notable from our data in Figure 3B that
introducing a S368Emutation leads to higher nuclear localization
of SIRT2 in resting cells; therefore, S368 phosphorylation could
regulate this process. Interestingly, activation of Akt and phos-
phatidylinositol 3-kinase (PI3K), which occurs during infection
with L. monocytogenes, was shown to promote general nucleartransport through phosphorylation of RanBP3 and, therefore,
could be involved in SIRT2 relocalization (Yoon et al., 2008).
Although the machinery for SIRT2 nuclear import remains to be
determined, we show that S25 dephosphorylation is the signal
required for chromatin association of SIRT2. Importantly, our
data indicate that only isoform 1 of SIRT2 is able to bind to
chromatin, as isoform 2 lacks S25, strongly suggesting that
different isoforms have different localizations and functions.
We, therefore, propose a two-step mechanism for SIRT2
localization during infection in which bacterial presence first
induces the accumulation of SIRT2 in the nucleus and then an
association with chromatin.Cell Reports 23, 1124–1137, April 24, 2018 1133
Interestingly, in non-resting cells, SIRT2 nuclear localization
has been observed. For instance, SIRT2 accumulates in the nu-
cleus in a cell-cycle-dependent manner and upon exposure to
ionizing radiation (Inoue et al., 2007; Vaquero et al., 2006). Impor-
tantly for human health, SIRT2 nuclear localization was found to
correlate with different cancer prognoses. In tissue samples from
patients with glioblastoma, SIRT2 is mainly nuclear, but in con-
trol cells, it is predominantly cytoplasmic. Moreover, the higher
the percentage of nuclear SIRT2, the more severe the patient
prognosis (Imaoka et al., 2012). Here, we have identified a
PTM, serine 25 phosphorylation, which is necessary for SIRT2
targeting and binding to chromatin and for H3K18 deacetylation.
Therefore, along with reports correlating hypoacetylation of
H3K18 with poor cancer prognosis (Manuyakorn et al., 2010;
Seligson et al., 2009), we hypothesize that S25 could be a critical
residue during cellular transformation and cancer.
Infection has revealed a role for SIRT2 in transcriptional
repression, which is the function of the yeast homolog protein
Sir2. Sequence analysis revealed that SIRT2 is localized in the
same phylogenetic branch as Sir2 and SIRT1. Sir2 is a bona
fide transcriptional repressor in yeast by being recruited to chro-
matin and causing silencing at repeated DNA sequences at the
telomeres and mating-type or rDNA loci. Silencing requires the
deacetylation of histones H3 and H4, and Sir2 shows high de-
acetylase activity toward these proteins (Blander and Guarente,
2004; North and Verdin, 2004). Interestingly, serine 25, along
with surrounding serines 23 and 27 of SIRT2, is conserved in
SIR2 of the fission yeast Schizosaccharomyces pombe, sug-
gesting that phosphorylation might also regulate SIR2 function.
To date, SIRT1 was considered to be the nuclear sirtuin and
has been shown to associate with chromatin and work as a tran-
scriptional repressor through its deacetylase activity (Jing and
Lin, 2015). SIRT1 forms a repressive complex with a variety of
chromatin-associated factors, such as the demethylase LSD1
(Mulligan et al., 2011). However, our studies with infection re-
vealed that SIRT2, similarly to SIRT1 and yeast SIR2, functions
in the nucleus as a transcriptional repressor.
PPM1A and PPM1B are metal-ion-binding phosphatases that
belong to the PPM (protein phosphatase Mn2+/Mg2+) family
and function as monomeric units (Lammers and Lavi, 2007).
The observations that we report in this paper raise several
questions. Indeed, by co-immunoprecipitation, we observe a
complex forming between PPM1A, PPM1B, and SIRT2. In addi-
tion, our siRNA experiments show that knocking down either
PPM1A or PPM1B abolishes the deacetylation of K18 observed
upon infection. Taken together, these data suggest that the
entire complex is necessary for SIRT2 function at the chromatin
fraction, and loss of any one component disassembles the com-
plex and blocks SIRT2 activity. In addition, as PPM1A is present
in the nucleus in resting cells, we hypothesize that the complex
forms in the nuclear compartment. The exact molecular mecha-
nism of how this complex forms and whether it is necessary for
other PPM1A/B substrates will have to be addressed. Another
question that arises is in regard to how these phosphatases ac-
quire specificity toward their substrate. Indeed, Listeria infection
activates PPM1A and PPM1B to specifically target serine 25 and
not serine 368 of SIRT2. Furthermore, another target of PPM1A,
P65 (Lu et al., 2014), is not dephosphorylated during infection1134 Cell Reports 23, 1124–1137, April 24, 2018(Figure S6). How specificity is achieved remains to be deter-
mined but has been observed in many other systems (Lammers
and Lavi, 2007). Our study adds SIRT2 to the list of substrates of
PPM1A and PPM1B.
Our data reveal that infection relocalizes PPM1A and
PPM1B, along with SIRT2, to chromatin during infection. In
resting cells, the subcellular localization for PPM1A has been
shown to be nuclear, while it is cytoplasmic for PPM1B (Chen
et al., 2015; Li et al., 2015; Lin et al., 2006; Lu et al., 2014).
Although PPM1B interacts with nuclear proteins and has a
role in transcriptional regulation, PPM1B has only been found
to localize to the nucleus during differentiation of adipocytes
(Abraham et al., 2015; Prajapati et al., 2004; Tasdelen et al.,
2013; Yien and Bieker, 2012). To our knowledge, infection
with L. monocytogenes is the first exogenous stimulus that in-
duces nuclear localization of PPM1B. Translocation and further
co-immunoprecipitation of PPM1A and PPM1B with SIRT2
suggest that a complex between these proteins is formed
during infection. Whether the complex forms in the cytoplasm
with SIRT2 and PPM1B or once translocation to the nucleus
has taken place remains to be determined.
In summary, among the new 21 PTMs of SIRT2 that we iden-
tified, we focused on S25 dephosphorylation, which is induced
by L. monocytogenes infection in order to hijack SIRT2 and
impose its role as a transcriptional modulator. We show that
S25 is dephosphorylated during infection, but other stimuli could
induce the same modification, thereby regulating the activity,
substrate specificity, and subcellular localization of SIRT2. The
relatively high number of PTMs identified for SIRT2 reflects the
various functions of this protein in important cellular processes
such as metabolism, aging, cancer, and senescence, and they
deserve closer attention, as they could be the key to specific
treatments for these diseases.EXPERIMENTAL PROCEDURES
Antibodies
Antibodies used in this study are listed as follows; rabbit: anti-acetyl-histone
H3K18 (Cell Signaling Technology, 9675), anti-histone H3 (Cell Signaling Tech-
nology, 9715), anti-GFP tag (Thermo Fisher Scientific, A-11122), anti-PPM1B
(Abcam, ab137811), anti-PPM1B (Bethyl Laboratories, A300-887A), anti-
Phospho-NF-kB p65 (Ser536) (93H1) (Cell Signaling Technology, #3033),
anti-PP1 alpha (Upstate Biotechnology, #07-273), anti-CRM1 (H-300)
(Santa Cruz Biotechnology, sc-5595), anti-SIRT2 (Abcam, ab67299), and
anti-EF-Tu (Archambaud et al., 2005); mouse: anti-a-tubulin (Sigma, T6074),
anti-PPM1A [p6c7] (Abcam, ab14824), anti-NFkB p65 (F-6) (Santa Cruz
Biotechnology, sc-8008), and anti-FLAG M2 (F3165, Sigma).
Cell Culture, Infections, and Inhibitors
The bacterial strains that we used in this study are indicated in the Supple-
mental Experimental Procedures. L. monocytogenes strains were grown in
brain-heart infusion medium (Difco Laboratories, Detroit, MI, USA) at 37C.
For infection experiments, bacteria were grown to mid-exponential phase, at
an optical density 600 nm of 1.
HeLa (ATCC, CCL-2) cells were cultured in minimum essential medium
(MEM) plus GlutaMAX (GIBCO, Waltham, MA, USA) supplemented with
1 mM sodium pyruvate (GIBCO), 0.1 mM nonessential amino acid solution
(GIBCO), and 10% fetal bovine serum (FBS). MEFs were cultured in DMEM
with 2 mM GlutaMAX (GIBCO) supplemented with 10% FBS. Sirt2+/+ and
Sirt2/ primary MEFs were isolated from isogenic mice and transformed
with a plasmid expressing SV40 large T antigen (BUG 3790).
For the purpose of infection experiments, HeLa cells and MEFs were
grown to semiconfluence, at which point they were serum-starved for 24 hr
and 30 min, respectively, before use. Exponential-phase bacteria were
washed twice in PBS and added to cells at an MOI of 50:1, unless otherwise
mentioned. After 1 hr of infection, cells were washed with serum-low medium,
and 10 mg/mL gentamycin was added to kill extracellular bacteria. Infections
were carried out for 5 hr and 24 hr.
For experiments involving pharmacological inhibitors, cells were pretreated
for 24 hr prior to infection with DMSO or sanguinarine chloride (0.5 mM, Tocris,
2302).
Cloning
SIRT2-GFP, SIRT2-S25E-GFP (adjacent serine residues Ser23/ Glu23 and
Ser27 / Glu27 were also mutated), SIRT2-S25A, and SIRT2-S368E-GFP
were generated by PCR amplification of a G-block gene fragment (Integrated
DNA Technologies) containing the sequence ofWTSIRT2 isoform 1 cDNA (389
aa) using primers SIRT2 forward (fwd) and SIRT2 reverse (rev) and cloned at
the EcoRI site of the pEGFP-N2 plasmid (Supplemental Experimental
Procedures). SIRT2 isoform 2 (352 aa) was PCR-amplified with primers
SIRT2-Iso2 fwd and SIRT2-rev from a GST-SIRT2 fusion (pGEX-4T2 back-
bone), which was a gift from Bernhard L€uscher: the resulting insert was cloned
at the EcoRI site of the pEGFP-C1 vector. PPM1A-FLAG and PPM1B-FLAG
were generated using G-blocks containing cDNA sequence, PCR-amplified,
respectively, with primer pairs PPM1A-fw1/PPM1A-FLAG-rev and PPM1B-
fw/PPM1B-FLAG-Rev (Supplemental Experimental Procedures), and cloned
into the BamHI and NotI sites of the pCDNA 3.1(+) vector. Catalytically dead
PPM1B [Arg179/ Gly179 (R179G)] was constructed by sewing reaction using
the following primers: (1) PPM1B fwd/PPM1B 05 rev, (2) PPM1B 05/PPM1B-
FLAG-rev, and (3) PPM1B fwd/PPM1B-FLAG-rev (Supplemental Experimental
Procedures), followed by insertion at the EcoRI and NotI sites of the
pcDNA3.1(+) vector. PPM1B-mRuby was generated by cloning PPM1B into
the EcoRI site of the pmRuby2-C1 vector.
Transfections
HeLa cells were reverse transfected with commercial siRNA from Dharmacon
(Lafayette, CO, USA) for PPM1A (ON-TARGETplus SMARTpool L-009574-
00-0005) and PPM1B (ON-TARGETplus SMARTpool L-008281-01-0005),
Pan PP1 (sc-43545, Santa Cruz Biotechnology), or control scramble siRNA
(ON-TARGETplus Non-targeting Pool D-001810-10-05). Briefly, 25 nM siRNA
is mixed with 4 mL Lipofectamine RNAiMAX (Invitrogen) in a 400-mL volume.
After 15 min of incubation, 23 105 cells were added per well of a 6-well plate.
Cells were assayed 48 and 72 hr after siRNA transfection.
For transfection of plasmid DNA, HeLa cells were seeded at a density of
2 3 105 cells per well of a 6-well plate the day prior to transfection. Briefly,
1.5 mg DNA (per well) was diluted in MEM without FBS and incubated with
Lipofectamine LTX (Invitrogen) for 30 min. Lipofectamine-DNA complexes
were incubated with cells for 4 hr and were assayed 48 hr after transfection.
For larger scale transfection, volumes were adjusted proportionally.
MEFswere transfected using the AmaxaMouse/RatHepatocyteNucleofector
Kit (Lonza, VPL-1004) or the jetPRIME Transfection Kit (Polyplus-transfection).
Briefly, 1.5 3 106 cells (per well of a 6-well plate) were resuspended in 100 mL
nucleofection solution and electroporated using an Amaxa Nucleofection II
device (program T-30). jetPRIME transfections were performed according to
the manufacturer’s protocol. Cells were assayed 24 hr after transfection.
Immunoblotting and Cell Fractionation
Total cell lysates were harvested in 23 Laemmli buffer (124 mM Tris-Cl
[pH 6.8], 4% SDS, 20% glycerol, 0.02% bromophenol blue, 0.03% DTT).
Samples were boiled at 95C for 5 min and sonicated for 5 s. After running
on acrylamide gels, proteins were transferred using an iBLOT transfer system
(Invitrogen) (program P0, 7 min), blocked in milk for 1 hr at room temperature
and incubated with primary antibody overnight at 4C. Membranes were
washed in Tris-buffered saline-Tween (50 mM Tris [pH 8], 15 mM NaCl,
0.1% Tween) and incubated with horseradish-peroxidase-conjugated
secondary antibody for 1 hr at room temperature, and blots were revealed
with ECL-2 (Pierce, Waltham, MA, USA). Quantification of western blots was
performed using the ChemiDoc (Bio-Rad) and associated software.Cell fractionation was conducted as previously described (Eskandarian
et al., 2013).
Immunofluorescence and Live-Cell Imaging
Cells were fixed in 4% paraformaldehyde (Electron Microscopy Sciences,
Hatfield, PA, USA) for 10 min at room temperature and permeabilized in
0.3% Triton X-100 (Sigma) for 15 min. Coverslips were incubated with primary
and secondary antibodies in 1% BSA + 0.1% Tween 100 and mounted on
microscopy glass slides using Fluoromount G (Interchim, Montluc¸on, France).
Images were acquired using an inverted wide-field fluorescence microscope
(AxioVert 200M, Carl Zeiss Microscopy, Jena, Germany) equipped with an
EMCCD Neo camera (Andor, Belfast, Northern Ireland) and the software
MetaMorph (Molecular Devices, Sunnyvale, CA, USA). Live-cell imaging was
performed for 120 min on a Zeiss Axio Observer spinning-disk confocal micro-
scope equipped with a 633 oil objective and driven by the MetaMorph soft-
ware. Images were acquired every 2 min for 2 hr.
qRT-PCR
Total mRNA was extracted using the RNeasy Kit (QIAGEN) and quantified
using BioAnalyzer (Agilent). Reverse transcription (RT) was performed on
1 mg RNA with the iScript cDNA Synthesis Kit (Bio-Rad). qPCR was done on
a 1:10 dilution of RT product using the SsoFast EvaGreen Supermix (Bio-
Rad) and run on a MyIQ device (Bio-Rad). Data were analyzed using the
Bio-Rad software and the DDCt method.
Immunoprecipitation
Cells were scraped and lysed in RIPA buffer (10 mM Tris-Cl [pH 7.5], 150 mM
NaCl, 0.5 mM EDTA, 0.1% SDS, 1% Triton X-100, 1% deoxycholate) supple-
mented with 25 U benzonase nuclease (Millipore), 13 cOmplete EDTA-free
Protease Inhibitor Cocktail (Roche), and 13 PhosSTOP phosphatase inhibitor
(Roche). Immunoprecipitations were performed overnight on a rotating wheel
at 4C. SIRT2-GFP was immunoprecipitated with GFP-TRAP agarose beads
(ChromoTek), according to the manufacturer’s protocol. Elution was per-
formed by boiling the samples in Laemmli buffer + DTT. Immunoprecipitation
of FLAG-tagged proteins was performed with Anti-FLAG M2 Magnetic Beads
(Sigma), according to the manufacturer’s protocol. FLAG-tagged proteins
were eluted by competition with 100 mg/mL FLAG Peptide (F4799, Sigma).
Drp1-FLAG construct (unpublished data) was used as a control.
Mass Spectometry Sample Preparation
Immunoprecipitated SIRT2-GFP from fractionated cells or whole-cell lysates
was separated by SDS-PAGE on a 4%–15% polyacrylamide gel (Bio-Rad)
and stained by colloid Coomassie blue (Invitrogen). From each sample, the
SIRT2 gel band was excised and washed with H2O, incubated for 15 min
with water/acetonitrile (1:1, v/v), and incubated for 15 min with 100% acetoni-
trile before the band was dried completely in a vacuum concentrator. 0.25 mg
sequencing-grade trypsin (Promega) in 50 mM ammonium bicarbonate in wa-
ter/acetonitrile (9:1, v/v) was added to the dried gel slices, and proteins were
digested overnight at 37C. Peptides eluted from every gel slice were dried
completely in a vacuum concentrator and re-dissolved in 20 mL solvent A
(0.1% formic acid in water/acetonitrile; 98:2, v/v) for liquid chromatography-
tandem MS (LC-MS/MS) analysis.
PTM Discovery by HCD Fragmentation
For accurate mapping of SIRT2 phosphorylation sites, samples were analyzed
by LC-MS/MS on a Q Exactive instrument (Thermo Fisher Scientific) coupled
to an EASY-nLC 1000 system (Thermo Fisher Scientific). 8 mL peptides in
solvent A were loaded on a reverse-phase column (made in house, 75 mm
inner diameter [i.d.] 3 150 mm, 1.9-mm beads, ReproSil-Pur C18, Dr. Maisch,
Ammerbuch-Entringen, Germany) and eluted by an increase in solvent B
(0.1% formic acid in acetonitrile) in linear gradients from 2% to 30% in
55 min and then from 30% to 50% in 10 min, all at a constant flow rate of
300 nL/min. The mass spectrometer was operated in data-dependent mode,
automatically switching between MS and MS/MS acquisition for the 10 most
abundant ion peaks per MS spectrum. Full-scan MS spectra (300–2000 m/z)
were acquired at a resolution of 70,000 after accumulation to a target value
of 1,000,000, with a maximum fill time of 250 ms. The 10 most intense ionsCell Reports 23, 1124–1137, April 24, 2018 1135
above a threshold value of 10,000were isolated (windowof 2.0 Thompson [Th])
for HCD fragmentation at a normalized collision energy of 28% after filling the
trap at a target value of 100,000 for amaximum of 100mswith an underfill ratio
of 1%. The S-lens RF level was set at 55, and we excluded precursor ions with
single and unassigned charge states from fragmentation selection.
Data analysis was performed with MaxQuant (v1.5.6.5) (Cox and Mann,
2008) using the Andromeda search engine, with default search settings
including a false discovery rate set at 1% on both the peptide and protein
levels. Spectra were searched against the human proteins in the UniProtKB/
Swiss-Prot database (database release version of January 2017 containing
20,172 human protein sequences; http://www.uniprot.org). The mass toler-
ances for precursor and fragment ions were set to 4.5 and 20 ppm, respec-
tively, during the main search. Enzyme specificity was set as C-terminal to
arginine and lysine, also allowing cleavage at proline bonds with a maximum
of two missed cleavages. Variable modifications were set to oxidation of
methionine residues; acetylation of protein N termini; acetylation of lysine
residues; di-glycine modification of lysine residues; and phosphorylation of
serine, threonine, and tyrosine residues. The minimum score for modified pep-
tides was set to 20, and a minimum of 1 unique or razor peptide was required
for protein identification. The SIRT2 modification sites in the GlyGly (K) sites,
Phospho (STY) sites, and Acetyl (K) sites in MaxQuant are listed in Figure 1C.
Phosphosite Determination by ETD Fragmentation
For accurate mapping of the SIRT2 phosphorylation sites, samples were
analyzed on an ETD-enabled LTQ Orbitrap Velos instrument (Thermo Fisher
Scientific) coupled to an UltiMate 3000 RSLCnano UHPLC System (Thermo
Fisher Scientific). 5 mL peptides in solvent A was loaded onto a C18 trap col-
umn (Acclaim PepMap 300, 5 mm, 300 A˚, 300 mm i.d. 3 5 mm; Thermo Fisher
Scientific), desalted during 5 min, and then separated on a 20-cm homemade
C18 column (3-mm particles, Dr. Maisch, Ammerbuch-Entringen, Germany) by
a one-step gradient (from 2.0% to 65% solvent B (0.1% formic acid in water/
acetonitrile [20:80, v/v]) in 59 min, all at a constant flow rate of 300 nL/min. MS
data were acquired using Xcalibur software (v2.1) with a survey scan (300–
2,000 m/z) analyzed into the Orbitrap mass analyzer at a resolution setting
of 60,000 in profile mode. ETD fragmentation was triggered for the 15 most
intense precursor ions included in a parent mass list corresponding to the
different forms of S368 and S25 peptides. Fragments were analyzed in the
linear ion trap. The automatic gain control (AGC) targets for MS and MS/MS
scans were set to 1,000,000 and 5,000, respectively. The isolation width
was set to 2.0 m/z, and the activation time was set to 150 ms. Selected ions
were dynamically excluded for 15 s.
The ion chromatograms of the peptides of interest (XICs) were extracted
manually using the Qual Browser software in Xcalibur (v2.2). Extracted ion cur-
rent was searched at 5 ppm in MS1, and all XIC values were normalized over
the full total ion current of the injection. For peptide annotation, raw data files
were analyzed using the MaxQuant software, v.1.5.3.8 (Cox and Mann, 2008),
with the Andromeda search engine (Cox et al., 2011). The acquisitions were
searched against a human database (UniProt databases containing 89,706 en-
tries, including 42,034 SwissProt entries, downloaded on January 13, 2015).
The digestion mode was set to trypsin, and a maximum of two missed cleav-
ages were allowed. N-terminal acetylation and methionine oxidation were set
as variable modifications, and cysteine carbamidomethylationwas set as fixed
modification. For the phosphorylation of S25- and S368-containing peptides,
additional phosphorylation of S/T/Ywas set to variable modification. False dis-
covery rates were fixed at 1% at both peptide and protein levels.
Statistical Analysis
The p values were calculated using a paired Student’s t test. Values of p < 0.05
were considered significant. Values of p < 0.05 were ranked as *p < 0.05,
**p < 0.01, and ***p < 0.001.
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